Under the agreement, Smith & Nephew will hold distribution rights for Graftys’ fast-setting, macroporous calcium phosphate bone void filler in the United States with the potential for additional countries around the world.
Graftys produces an injectable, hard-setting resorbable calcium phosphate bone substitute which provides a support scaffold for bone growth. It can also be mixed and applied in situ.
Read the release about the partnership between Graftys and Smith & Nephew.
Related Articles on Smith & Nephew:
Smith & Nephew Introduces Short Modular Femoral Hip System
Smith & Nephew Introduce TWINFIX Suture Anchor for Rotator Cuff Repair
Smith & Nephew, Nanotope Partner in Cartilage Regeneration Project
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
